Home Equities Score Vertex Pharmaceuticals Inc. (VRTX) stock plunged during after-hour. Here’s what you should...

Vertex Pharmaceuticals Inc. (VRTX) stock plunged during after-hour. Here’s what you should know

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) stock gained by 1.5% at last close while the VRTX stock price declines during after-hour by 12.95%. Vertex is a multinational biotechnology business that invests in scientific research to develop life-changing treatments for patients suffering from critical illnesses. Multiple drugs approved by VRTX treat the underlying cause of cystic fibrosis (CF).

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is happening?

In a Phase 2 proof-of-concept study, VX-864 experienced high, reliable, and statistically significant rises in mean functional alpha-1 antitrypsin (fAAT) levels of 2.2 to 2.3 micromolar from baseline in individuals with alpha-1 antitrypsin deficiency (AATD) with the PiZZ genotype along with all three dose groups of VX-864 relative to placebo.  In the Phase 2 trial, VX-864 was usually well tolerated.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

These findings show that an oral small molecule corrector that promotes normal folding of the mutant Z-AAT protein can raise plasma levels of fAAT in AATD patients. Although the findings show that the mechanism is working, the amount of treatment impact seen in this research is unlikely to translate into significant therapeutic benefit. As a result, Vertex will not move VX-864 into late-stage development, preferring to focus on developing new small molecule correctors with the potential to improve clinical effectiveness.

At day 28 of therapy, all VX-864 dosing groups showed highly statistically significant increases in plasma fAAT levels from baseline, if compared to placebo, indicating that the trial fulfilled its primary aim. In comparison to the placebo, treatment with VX-864 resulted in a mean rise of 2.2 to 2.3 micromolar in fAAT levels across the three dosage groups investigated.

Furthermore,

Only one patient in this trial did not finish therapy. There were no withdrawals owing to adverse events (AEs) or serious adverse events (SAEs) that were thought to be connected to the study medication. The majority of adverse events were mild to moderate in intensity and did not interfere with therapy.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

The information gathered is expected to aid in the optimization of Vertex’s small molecule corrector strategy in AATD, as well as the quick development of a portfolio of novel compounds with improved clinical effectiveness into the clinic by 2022. In addition, the VX-864 study’s findings are likely to improve clinical trial design, recruitment, and execution for future assets.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Bit Digital Inc. (BTBT) stock plunges during the current market trading session. What is happening?

Bit Digital Inc. (NASDAQ: BTBT) stock declined by -1.43% in the current market trading as of this writing. Bit Digital, Inc. is a Bitcoin...

Celsion Corporation (CLSN) stock gains in Pre-Market: Let’s Find out why.

Shares of Celsion Corporation (CLSN) stock were gaining in the pre-market today on June 10, 2021, following the announcement of new appointments by Celsion...

Medley Management Inc. (MDLY) stock soars during pre-market trading, given no recent update

Medley Management Inc. (NASDAQ: MDLY) stock gained by 8.96% at last close while the MDLY stock price rises by 108.90% in the pre-market trading...

Sphere 3D Corp. (ANY) stock surged during after-hour session. Why so?

Sphere 3D Corp. (NASDAQ: ANY) stock gained by 10.5% at last close while the ANY stock price soars further during the after-hour session by...

Geo Group Inc. (GEO) stock soars during current market trading. What has been happening?

Geo Group Inc. (NASDAQ: GEO) stock gained by 51.42% in the current market trading session. There is no recent news available regarding this surge...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam